{"name": "Osprey Pharmaceuticals USA",
 "permalink": "osprey-pharmaceuticals-usa",
 "crunchbase_url": "http://www.crunchbase.com/company/osprey-pharmaceuticals-usa",
 "homepage_url": "http://www.ospreypharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1998,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "inflammatory, immune, disease, medication",
 "alias_list": "",
 "email_address": "info@ospreypharma.com",
 "phone_number": "",
 "description": "Inflammatory/immune disease medications",
 "created_at": "Fri Jun 19 00:33:13 UTC 2009",
 "updated_at": "Tue Mar 16 11:45:09 UTC 2010",
 "overview": "\u003Cp\u003EOsprey Pharmaceuticals USA is a clinical stage company focused on the development of novel protein therapeutics for the treatment of inflammatory and immune diseases.\u003C/p\u003E\n\n\u003Cp\u003EThe company is advancing a pipeline of proprietary fusion protein therapeutics known as Leukocyte Population Modulators (LPMs) that are designed to selectively target and neutralize chemokine-activated leukocytes underlying a variety of inflammatory and immune diseases.\u003C/p\u003E\n\n\u003Cp\u003EThe Company\u00e2\u20ac\u2122s lead candidate, CCL2-LPM targeting the CCR2 chemokine receptor expressed by certain pathologically activated leukocytes is in a Phase Ib clinical trial for the treatment of IgA nephropathy.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       16],
      "assets/images/resized/0004/9529/49529v1-max-150x150.jpg"],
     [[250,
       27],
      "assets/images/resized/0004/9529/49529v1-max-250x250.jpg"],
     [[450,
       50],
      "assets/images/resized/0004/9529/49529v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Jack",
      "last_name": "M. Anthony",
      "permalink": "jack-m-anthony",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$16.9M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.ospreypharma.com/#investment",
    "source_description": "Osprey Pharmaceuticals",
    "raised_amount": 11000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 5,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Burrill \u0026 Company",
         "permalink": "burrill-co",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0402/50402v1-max-150x150.png"],
             [[250,
               43],
              "assets/images/resized/0005/0402/50402v1-max-250x250.png"],
             [[250,
               43],
              "assets/images/resized/0005/0402/50402v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novo Nordisk",
         "permalink": "novo-nordisk",
         "image":
          {"available_sizes":
            [[[70,
               49],
              "assets/images/resized/0004/9782/49782v1-max-150x150.png"],
             [[70,
               49],
              "assets/images/resized/0004/9782/49782v1-max-250x250.png"],
             [[70,
               49],
              "assets/images/resized/0004/9782/49782v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Yasuda Enterprise Development",
         "permalink": "yasuda-enterprise-development",
         "image":
          {"available_sizes":
            [[[150,
               96],
              "assets/images/resized/0005/4828/54828v2-max-150x150.png"],
             [[225,
               145],
              "assets/images/resized/0005/4828/54828v2-max-250x250.png"],
             [[225,
               145],
              "assets/images/resized/0005/4828/54828v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "GeneChem",
         "permalink": "genechem",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0006/1153/61153v2-max-150x150.png"],
             [[250,
               73],
              "assets/images/resized/0006/1153/61153v2-max-250x250.png"],
             [[283,
               83],
              "assets/images/resized/0006/1153/61153v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BDC Venture Capital",
         "permalink": "bdc-venture-capital-2",
         "image":
          {"available_sizes":
            [[[115,
               57],
              "assets/images/resized/0001/1190/11190v1-max-150x150.png"],
             [[115,
               57],
              "assets/images/resized/0001/1190/11190v1-max-250x250.png"],
             [[115,
               57],
              "assets/images/resized/0001/1190/11190v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Western Technology Investment",
         "permalink": "western-technology-investment",
         "image":
          {"available_sizes":
            [[[82,
               60],
              "assets/images/resized/0014/5446/145446v4-max-150x150.png"],
             [[82,
               60],
              "assets/images/resized/0014/5446/145446v4-max-250x250.png"],
             [[82,
               60],
              "assets/images/resized/0014/5446/145446v4-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://deals.venturebeat.com/?p=107840",
    "source_description": "Osprey picks up $3.8M more for immune disease treatments",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2009,
    "funded_month": 5,
    "funded_day": null,
    "investments":
     []},
   {"round_code": "unattributed",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 5920000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 1,
    "funded_day": 30,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Cascadia Partners",
         "permalink": "cascadia-partners",
         "image":
          {"available_sizes":
            [[[150,
               53],
              "assets/images/resized/0010/0624/100624v1-max-150x150.jpg"],
             [[217,
               77],
              "assets/images/resized/0010/0624/100624v1-max-250x250.jpg"],
             [[217,
               77],
              "assets/images/resized/0010/0624/100624v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Desjardins Venture Capital",
         "permalink": "desjardins-venture-capital",
         "image":
          {"available_sizes":
            [[[150,
               45],
              "assets/images/resized/0002/3526/23526v1-max-150x150.jpg"],
             [[171,
               52],
              "assets/images/resized/0002/3526/23526v1-max-250x250.jpg"],
             [[171,
               52],
              "assets/images/resized/0002/3526/23526v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "GeneChem",
         "permalink": "genechem",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0006/1153/61153v2-max-150x150.png"],
             [[250,
               73],
              "assets/images/resized/0006/1153/61153v2-max-250x250.png"],
             [[283,
               83],
              "assets/images/resized/0006/1153/61153v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Ventures West",
         "permalink": "ventures-west",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0001/0785/10785v1-max-150x150.png"],
             [[240,
               74],
              "assets/images/resized/0001/0785/10785v1-max-250x250.png"],
             [[240,
               74],
              "assets/images/resized/0001/0785/10785v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BDC Venture Capital",
         "permalink": "bdc-venture-capital-2",
         "image":
          {"available_sizes":
            [[[115,
               57],
              "assets/images/resized/0001/1190/11190v1-max-150x150.png"],
             [[115,
               57],
              "assets/images/resized/0001/1190/11190v1-max-250x250.png"],
             [[115,
               57],
              "assets/images/resized/0001/1190/11190v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "",
    "address2": "",
    "zip_code": "",
    "city": "San Francisco",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.775196,
    "longitude": -122.419204}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        128],
       "assets/images/resized/0004/9528/49528v1-max-150x150.png"],
      [[250,
        214],
       "assets/images/resized/0004/9528/49528v1-max-250x250.png"],
      [[450,
        385],
       "assets/images/resized/0004/9528/49528v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}